Mrv1909 02092322482D 3 0 0 0 0 0 999 V2000 0.4125 0.0000 0.0000 O 0 6 0 0 0 0 0 0 0 0 0 0 2.7696 0.0000 0.0000 O 0 6 0 0 0 0 0 0 0 0 0 0 -0.4125 0.0000 0.0000 Hf 0 0 0 0 0 0 0 0 0 0 0 0 M CHG 3 1 -2 2 -2 3 4 M END > DB17508 > drugbank > [O--].[O--].[Hf+4] > InChI=1S/Hf.2O/q+4;2*-2 > WIHZLLGSGQNAGK-UHFFFAOYSA-N > HfO2 > 210.49 > 211.93639 > 1 > 3 > -4.1036912103859217e-10 > 0.9475908 > 1 > 0 > 0 > 0 > hafnium(4+) dioxidandiide > -0.6519999999999999 > 0 > 0 > 0 > 0 > 15.699999999999998 > -1.8000000000000003 > 0.0 > 13.1149 > 0 > 1 > 2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-5H,6H,8H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile > 1 > DB17508 > investigational > Hafnium oxide > Hafnium oxide-containing nanoparticles nbtxr3 $$$$